Skip to content

Mitochondrial Remodeling After Exercise

Mitochondrial Remodeling After Exercise

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04103424
Enrollment
31
Registered
2019-09-25
Start date
2019-08-23
Completion date
2022-12-03
Last updated
2024-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance, Metabolic Disease, Mitochondrial Metabolism, Overweight and Obesity, Sedentary Lifestyle

Brief summary

Regulation of mitochondrial health in overweight and obese individuals may be impaired. The purpose of this study is to identify impairments in regulation of mitochondrial health within skeletal muscle and to determine if short-term exercise training (2-weeks) can reverse such impairments. The investigator's hypothesis is that pathways that serve to degrade poorly functioning mitochondria in overweight and obese individuals are down-regulated, but that short-term exercise training can restore these pathways to improve skeletal muscle mitochondrial function.

Interventions

BEHAVIORALShort-term Exercise Training

Participants will perform 2-weeks of supervised exercise training on a stationary bike.

Sponsors

Oregon State University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Participants will be asked to complete 2 screening visits to determine eligibility. If participants remain eligible, they will be asked to complete 2 metabolic study visits, 1 before and 1 after 2 weeks of supervised exercise training on a stationary bike.

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18-45 years * Body mass index (BMI) 18-45 kg/m2 * Sedentary (\<1 hour of planned exercise per week)

Exclusion criteria

* Regular exercise (\>1 hour of planned exercise per week) * Smoking, tobacco or nicotine use within the last 1-year * Fasting glucose \>126mg/dL * Hypertension (systolic pressure \>140 mmHg or diastolic pressure \>90 mmHg) * Chronic metabolic or cardiovascular health conditions * Pregnant, nursing, irregular menses or post-menopausal * Lidocaine allergy * Certain medications * Physical limitations that prevent safe or successful exercise completion * Diminished capacity for consent

Design outcomes

Primary

MeasureTime frameDescription
Change in skeletal muscle mitochondrial protein degradation peptide productsAfter 2-weeks of exercise training compared with before training.Skeletal muscle mitochondrial protein degradation peptide products after 2-weeks of exercise training compared with before training.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026